FdaApplication
NDA 220425
Identifiers
- fda_app_no: NDA220425
Properties
| Property | Value |
|---|---|
| applicant_name | ELEVAR THERAPEUTICS INC |
| application_type | NDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LYRFIGTU | LIRAFUGRATINIB HYDROCHLORIDE | 30MG | CAPSULE; ORAL |
| LYRFIGTU | LIRAFUGRATINIB HYDROCHLORIDE | 20MG | CAPSULE; ORAL |
2 products